De Meyer SF - Search Results

1

Platelets at work in primary hemostasis.

Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Broos K, et al. Among authors: de meyer sf. Blood Rev. 2011 Jul;25(4):155-67. doi: 10.1016/j.blre.2011.03.002. Epub 2011 Apr 14. Blood Rev. 2011. PMID: 21496978 Review.

2

New approaches for antithrombotic antiplatelet therapies.

Ulrichts H, Vanhoorelbeke K, Van De Walle G, Katsutani S, De Meyer S, Staelens S, Deckmyn H. Ulrichts H, et al. Curr Med Chem. 2004 Sep;11(17):2261-3. doi: 10.2174/0929867043364630. Curr Med Chem. 2004. PMID: 15379711 Review.

3

How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?

Xu G, Ulrichts H, Vauterin S, De Meyer SF, Deckmyn H, Teng M, Niu L. Xu G, et al. Among authors: de meyer sf. Toxicon. 2005 Apr;45(5):561-70. doi: 10.1016/j.toxicon.2004.11.017. Toxicon. 2005. PMID: 15777951

4

False positive results in chimeraplasty for von Willebrand Disease.

De Meyer SF, Pareyn I, Baert J, Deckmyn H, Vanhoorelbeke K. De Meyer SF, et al. Thromb Res. 2007;119(1):93-104. doi: 10.1016/j.thromres.2005.12.009. Epub 2006 Feb 2. Thromb Res. 2007. PMID: 16457874

5

Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.

De Meyer SF, Vanhoorelbeke K, Chuah MK, Pareyn I, Gillijns V, Hebbel RP, Collen D, Deckmyn H, VandenDriessche T. De Meyer SF, et al. Blood. 2006 Jun 15;107(12):4728-36. doi: 10.1182/blood-2005-09-3605. Epub 2006 Feb 14. Blood. 2006. PMID: 16478886 Free PMC article.

6

Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.

De Meyer SF, Vanhoorelbeke K, Ulrichts H, Staelens S, Feys HB, Salles I, Fontayne A, Deckmyn H. De Meyer SF, et al. Cardiovasc Hematol Disord Drug Targets. 2006 Sep;6(3):191-207. doi: 10.2174/187152906778249536. Cardiovasc Hematol Disord Drug Targets. 2006. PMID: 17017902 Review.

7

Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF.

Lenting PJ, de Groot PG, De Meyer SF, Vanhoorelbeke K, Pruss C, Lillicrap D, Marx I, Denis CV. Lenting PJ, et al. Among authors: de meyer sf, de groot pg. Blood. 2007 Mar 1;109(5):2267-8. doi: 10.1182/blood-2006-10-054718. Blood. 2007. PMID: 17312004 Free article. No abstract available.

8

The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha.

Szántó T, Schlammadinger A, Staelens S, De Meyer SF, Freson K, Pareyn I, Vauterin S, Hársfalvi J, Deckmyn H, Vanhoorelbeke K. Szántó T, et al. Among authors: de meyer sf. Thromb Haemost. 2007 Jul;98(1):178-85. Thromb Haemost. 2007. PMID: 17598011

9

Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor--collagen interaction in baboons.

De Meyer SF, Staelens S, Badenhorst PN, Pieters H, Lamprecht S, Roodt J, Janssens S, Meiring M, Vanhoorelbeke K, Bruwer A, Brown S, Deckmyn H. De Meyer SF, et al. Thromb Haemost. 2007 Dec;98(6):1343-9. doi: 10.1160/th07-05-0335. Thromb Haemost. 2007. PMID: 18064334

10

Inherited traits affecting platelet function.

Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Salles II, et al. Among authors: de meyer sf. Blood Rev. 2008 May;22(3):155-72. doi: 10.1016/j.blre.2007.11.002. Epub 2008 Jan 3. Blood Rev. 2008. PMID: 18180086 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters